Primary Care Clinical Digest

PRIMARY CARE CLINICAL DIGEST NOVEMBER 25, 2022 What is in this Issue?

COVID-19 Care in the Community update for primary care

1. COVID-19 Care in the Community update for primary care 2. Updated COVID-19 antiviral clinical guidance and Primary Care COVID-19 Quick Reference Guide 3. Changes to funding for Supervised RATs in primary care – Update coming on Monday 4. National Immunisation Programme Update - 25 November 2022 5. Invitation: Building the future of health virtual hui 2 December 6. Goodfellow Symposium - March 2023 7. ACC Cultural Safety and Competency framework 8. Capitation Review Report 9. Pharmac Update 10. Top viewing for the weekend COVID-19 outbreak response ● An update on summer planning and the COVID-19 response was given at a media briefing last week by Director-General and lead of the Public Health Agency, Dr Andrew Old, Manatū Hauora – Ministry of Health Chief Science Advisor Dr Ian Town and Te Whatu Ora – Health New Zealand Interim National Medical Director Dr Pete Watson. ● Updated data and statistics about COVID-19 are published regularly on the Manatū Hauora website, including cases and demographics, sources of cases, testing, Māori and Pacific peoples’ data, trends and insights, vaccine data and other resources. For example, here is the latest COVID-19 trends and insights report, which was released last Friday.

Monkey Pox (MPX) ● An updated version of the ‘MPX (monkeypox) – clinical update’ document has been added to the MPX information for clinicians page on the Manatū Hauora – Ministry of Health website. Expanded advice about isolating if you test positive for MPX has also been added Updated COVID-19 ● COVID-19 Care in the Community has updated the clinical antiviral clinical guidance guidance for COVID-19 antivirals and Primary Care COVID-19 and Primary Care COVIDQuick Reference Guide (both attached), and we will be grateful if 19 Quick Reference you can use these to inform your care from now on. These Guide documents will be available on the COVID-19 Advice for all health professional’s webpage. ● Key changes in the updated Primary Care COVID-19 Quick Reference Guide are as follows: o Predicted timings for symptom onset with Omicron o When to consider doing a PCR test o When to test asymptomatic people

o

Long COVID update and link to access the clinical guidelines for rehabilitation ● Changes to funding for Supervised RATs in primary care – We are expecting an update on this on Monday! We will keep you posted!

National Immunisation ● Addressing vaccine hesitancy and disinformation through Programme Update - 25 behavioural change – an address by Dr Alison Buttenheim November 2022 o invite you to attend a special National Immunisation Programme organised Webinar on Friday 2 December 2022 from 12.30pm to 1.30pm where Dr Alison Buttenheim will speak about behavioral science approaches to addressing vaccine hesitancy and disinformation. Dr Buttenheim has served on the National Academies of Sciences, Engineering and Medicine’s AdHoc Committee on a Framework for the Equitable Allocation of the COVID-19 Vaccine, and provided testimony on COVID-19 vaccine hesitancy to the US House of Representatives’ Committee on Science, Space, and Technology. o MS TEAMS meeting. Meeting ID: 422 421 309 671 Passcode: 6rMt9U ●

Second booster eligibility expanded o Last Wednesday there was an announcement of an extension of eligibility for a second COVID-19 booster to Māori and Pacific peoples aged 40-49 – available from Friday 18 November. o Direct communications - 55k Māori and Pacific people aged 40-49 who met the eligibility criteria for a second booster were sent an email or SMS on 18 November. The content of the communication was to inform them of the change in eligibility of second boosters following last week’s announcement, advising why second boosters are important; and should they wish to, how to book and get vaccinated. Individuals were directed to pharmacies, local Māori or Pacific health providers, and vaccination centres to have their second booster. They were also provided details to call Healthline for information and to book.

Following the email / SMS campaign, outreach calls commenced from Monday 21 November, with the automated journeys (email / SMS) being extended shortly – system-generated email/SMS messages delivered automatically when an individual becomes eligible. o Targeted radio advertising went live from Monday 21 November (focussed on iwi and Pacific radio stations).

This is in market till end of next week. o Updated print collateral is in production and will be available on Dropbox once ready. o The interactive digital tools on the Unite Against COVID19 and Karawhiua websites is now live. This interactive eligibility checker that consumers can use can be found at: Check your eligibility

o

●

The updated Ministry of Health website reflecting this change is found here: COVID-19 vaccine: Boosters | Ministry of Health NZ PCV13 at ProPharma, and Zostavax returns o

Invitation: Building the future of health virtual hui 2 December

●

Goodfellow Symposium March 2023 Auckland ACC Cultural Safety and Competency framework Capitation Review Report Pharmac Update: Primary Care Prescribers for the week ending 18 November 2022

●

Due to a quality assurance delay with PCV13 stock deliveries to the ProPharma sites – PCV13 will now be available for ordering on the following revised dates: ▪ ProPharma Auckland – Tuesday 22 November ▪ ProPharma Hamilton – Wednesday 23 November ▪ ProPharma Christchurch – Thursday 24 November ▪ ProPharma Wellington – Friday 25 November ▪ ProPharma Dunedin – Friday 25 November ▪ ProPharma Whangarei – Monday 28 November o For further information, please refer to ProPharma’s website here: www.fundedvaccines.co.nz. PCV13 (Prevenar) replaces PCV10 (Synflorix) from Thursday 1 December 2022. For more information please view IMAC’s recent webinar on PCV. o Zostavax returns ▪ Pharmac has advised that providers who have yet to exhaust all remaining Zostavax stock can return this to ProPharmat at an ambient temperature for destruction. All remaining Zostavax stock in the supply chain expires 25 December 2022. Instructions for returning Zostavax stock is the same as returning PCV10 stock.

Stakeholder virtual hui (last one for 2022) o o o

● ● ●

Friday 2nd of December 1:15pm – 2:00pm Link: https://myevents.nz/HealthNZ/buildingthefutureofhealth 1 o At this hui the focus will be on Te Whatu Ora's progress to date and hospital, specialist services and primary care preparedness for the coming months. https://www.goodfellowunit.org/symposium/programme

https://www.acc.co.nz/for-providers/provide-services/culturalsafety-and-competencies/ https://dpmc.govt.nz/publications/proactive-release-futurecapitation-funding-approach Decision to fund a new brand of meningococcal ACWY vaccine

Please follow this link to the Pharmac notification regarding a decision to fund a new brand of meningococcal ACWY vaccine (MenQuadfi).

See full notice attached for wider information

● Supply Issue/Update: o Somatropin (Omnitrope): Temporary alternative brand listed from 21 November More info here o Oestradiol (Estradot) patches: Supply issue update. More info here o Laxatives: Supply issues. More info here o Konsyl-D (Ispaghula (psyllium) husk) Pharmac website. ● Recall Notice: o Accuretic (quinapril and hydrochlorothiazide) tablets Pharmac website. ● Brand Change: ● Ramipril is a new ACE-Inhibitor being listed from 1/12/22 ● Capecitabine Viatris is the new brand of Capecitabine (replacing Capercit).